nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—JUN—Nephrin/Neph1 signaling in the kidney podocyte—NPHS2—membranous glomerulonephritis	0.0469	0.0687	CbGpPWpGaD
Irbesartan—EDNRA—Prostaglandin Synthesis and Regulation—TBXAS1—membranous glomerulonephritis	0.0398	0.0583	CbGpPWpGaD
Irbesartan—JUN—nephron tubule—membranous glomerulonephritis	0.0334	0.112	CbGeAlD
Irbesartan—JUN—epithelium—membranous glomerulonephritis	0.0328	0.11	CbGeAlD
Irbesartan—JUN—Nephrin/Neph1 signaling in the kidney podocyte—NPHS1—membranous glomerulonephritis	0.0317	0.0464	CbGpPWpGaD
Irbesartan—EDNRA—cortex of kidney—membranous glomerulonephritis	0.0314	0.105	CbGeAlD
Irbesartan—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—TBXAS1—membranous glomerulonephritis	0.03	0.0439	CbGpPWpGaD
Irbesartan—JUN—kidney—membranous glomerulonephritis	0.0294	0.0987	CbGeAlD
Irbesartan—JUN—cortex of kidney—membranous glomerulonephritis	0.0286	0.0961	CbGeAlD
Irbesartan—AGTR1—nephron tubule—membranous glomerulonephritis	0.0252	0.0846	CbGeAlD
Irbesartan—AGTR1—epithelium—membranous glomerulonephritis	0.0247	0.0829	CbGeAlD
Irbesartan—AGTR1—kidney—membranous glomerulonephritis	0.0221	0.0743	CbGeAlD
Irbesartan—AGTR1—cortex of kidney—membranous glomerulonephritis	0.0216	0.0724	CbGeAlD
Irbesartan—PTGS1—Eicosanoid Synthesis—TBXAS1—membranous glomerulonephritis	0.0195	0.0285	CbGpPWpGaD
Irbesartan—PTGS1—Prostaglandin Synthesis and Regulation—TBXAS1—membranous glomerulonephritis	0.0163	0.0238	CbGpPWpGaD
Irbesartan—Valsartan—ALB—membranous glomerulonephritis	0.0131	0.672	CrCbGaD
Irbesartan—JUN—CD40/CD40L signaling—CD40—membranous glomerulonephritis	0.0121	0.0177	CbGpPWpGaD
Irbesartan—CYP2C8—kidney—membranous glomerulonephritis	0.012	0.0403	CbGeAlD
Irbesartan—JUN—Fc-epsilon receptor I signaling in mast cells—PLA2G1B—membranous glomerulonephritis	0.0113	0.0166	CbGpPWpGaD
Irbesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—PLG—membranous glomerulonephritis	0.0111	0.0162	CbGpPWpGaD
Irbesartan—JUN—Calcium signaling in the CD4+ TCR pathway—CD40LG—membranous glomerulonephritis	0.011	0.0161	CbGpPWpGaD
Irbesartan—PTGS1—epithelium—membranous glomerulonephritis	0.0109	0.0364	CbGeAlD
Irbesartan—PTGS1—Arachidonic acid metabolism—TBXAS1—membranous glomerulonephritis	0.0108	0.0158	CbGpPWpGaD
Irbesartan—PTGS1—kidney—membranous glomerulonephritis	0.00973	0.0327	CbGeAlD
Irbesartan—JUN—CD40/CD40L signaling—CD40LG—membranous glomerulonephritis	0.00925	0.0136	CbGpPWpGaD
Irbesartan—JUN—IL12 signaling mediated by STAT4—HLA-DRB1—membranous glomerulonephritis	0.00862	0.0126	CbGpPWpGaD
Irbesartan—AGTR1—Allograft Rejection—CD40—membranous glomerulonephritis	0.00862	0.0126	CbGpPWpGaD
Irbesartan—CYP3A4—kidney—membranous glomerulonephritis	0.00813	0.0273	CbGeAlD
Irbesartan—CYP2D6—kidney—membranous glomerulonephritis	0.008	0.0269	CbGeAlD
Irbesartan—JUN—Physiological and Pathological Hypertrophy  of the Heart—RHOA—membranous glomerulonephritis	0.00772	0.0113	CbGpPWpGaD
Irbesartan—PTGS1—Phase 1 - Functionalization of compounds—TBXAS1—membranous glomerulonephritis	0.00758	0.0111	CbGpPWpGaD
Irbesartan—AGTR1—Allograft Rejection—HLA-DQA1—membranous glomerulonephritis	0.00748	0.011	CbGpPWpGaD
Irbesartan—JUN—S1P2 pathway—RHOA—membranous glomerulonephritis	0.00748	0.011	CbGpPWpGaD
Irbesartan—UGT1A3—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.00715	0.0105	CbGpPWpGaD
Irbesartan—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—membranous glomerulonephritis	0.00712	0.0104	CbGpPWpGaD
Irbesartan—CYP2C8—Arachidonic acid metabolism—TBXAS1—membranous glomerulonephritis	0.00699	0.0102	CbGpPWpGaD
Irbesartan—JUN—BCR signaling pathway—CD79A—membranous glomerulonephritis	0.00691	0.0101	CbGpPWpGaD
Irbesartan—AGTR1—Allograft Rejection—CD40LG—membranous glomerulonephritis	0.00661	0.00967	CbGpPWpGaD
Irbesartan—JUN—Osteopontin-mediated events—RHOA—membranous glomerulonephritis	0.0065	0.00951	CbGpPWpGaD
Irbesartan—Losartan—ALB—membranous glomerulonephritis	0.00639	0.328	CrCbGaD
Irbesartan—EDNRA—Endothelins—RHOA—membranous glomerulonephritis	0.00628	0.0092	CbGpPWpGaD
Irbesartan—CYP2C8—Cytochrome P450 - arranged by substrate type—TBXAS1—membranous glomerulonephritis	0.00604	0.00885	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—SPARC—membranous glomerulonephritis	0.00603	0.00883	CbGpPWpGaD
Irbesartan—AGTR1—Allograft Rejection—C3—membranous glomerulonephritis	0.00584	0.00855	CbGpPWpGaD
Irbesartan—CYP2C9—Arachidonic acid metabolism—TBXAS1—membranous glomerulonephritis	0.00569	0.00833	CbGpPWpGaD
Irbesartan—JUN—Signaling events regulated by Ret tyrosine kinase—RHOA—membranous glomerulonephritis	0.00541	0.00792	CbGpPWpGaD
Irbesartan—JUN—PDGF Pathway—RHOA—membranous glomerulonephritis	0.00541	0.00792	CbGpPWpGaD
Irbesartan—AGTR1—Allograft Rejection—HLA-DRB1—membranous glomerulonephritis	0.00532	0.00779	CbGpPWpGaD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—CD40—membranous glomerulonephritis	0.00525	0.00769	CbGpPWpGaD
Irbesartan—JUN—Validated nuclear estrogen receptor alpha network—C3—membranous glomerulonephritis	0.00516	0.00756	CbGpPWpGaD
Irbesartan—JUN—Osteopontin-mediated events—MMP9—membranous glomerulonephritis	0.00516	0.00756	CbGpPWpGaD
Irbesartan—JUN—B Cell Receptor Signaling Pathway—CD79A—membranous glomerulonephritis	0.00514	0.00752	CbGpPWpGaD
Irbesartan—JUN—IL1-mediated signaling events—IL1B—membranous glomerulonephritis	0.00508	0.00744	CbGpPWpGaD
Irbesartan—CYP2D6—Cytochrome P450 - arranged by substrate type—TBXAS1—membranous glomerulonephritis	0.00496	0.00726	CbGpPWpGaD
Irbesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL1B—membranous glomerulonephritis	0.00494	0.00724	CbGpPWpGaD
Irbesartan—CYP2C9—Cytochrome P450 - arranged by substrate type—TBXAS1—membranous glomerulonephritis	0.00492	0.0072	CbGpPWpGaD
Irbesartan—CYP2C8—Phase 1 - Functionalization of compounds—TBXAS1—membranous glomerulonephritis	0.0049	0.00717	CbGpPWpGaD
Irbesartan—CYP1A2—Arachidonic acid metabolism—TBXAS1—membranous glomerulonephritis	0.00486	0.00712	CbGpPWpGaD
Irbesartan—JUN—RhoA signaling pathway—RHOA—membranous glomerulonephritis	0.00482	0.00706	CbGpPWpGaD
Irbesartan—JUN—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—membranous glomerulonephritis	0.00448	0.00656	CbGpPWpGaD
Irbesartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—membranous glomerulonephritis	0.00445	0.00651	CbGpPWpGaD
Irbesartan—CYP1A2—Cytochrome P450 - arranged by substrate type—TBXAS1—membranous glomerulonephritis	0.0042	0.00615	CbGpPWpGaD
Irbesartan—JUN—IL2-mediated signaling events—RHOA—membranous glomerulonephritis	0.00417	0.0061	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—CD40—membranous glomerulonephritis	0.0041	0.006	CbGpPWpGaD
Irbesartan—JUN—TWEAK Signaling Pathway—MMP9—membranous glomerulonephritis	0.00405	0.00593	CbGpPWpGaD
Irbesartan—PTGS1—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.00403	0.0059	CbGpPWpGaD
Irbesartan—CYP2D6—Phase 1 - Functionalization of compounds—TBXAS1—membranous glomerulonephritis	0.00402	0.00589	CbGpPWpGaD
Irbesartan—JUN—Aryl Hydrocarbon Receptor Pathway—IL1B—membranous glomerulonephritis	0.00399	0.00584	CbGpPWpGaD
Irbesartan—CYP2C9—Phase 1 - Functionalization of compounds—TBXAS1—membranous glomerulonephritis	0.00398	0.00584	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—ABCA1—membranous glomerulonephritis	0.00395	0.00579	CbGpPWpGaD
Irbesartan—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—membranous glomerulonephritis	0.0038	0.00557	CbGpPWpGaD
Irbesartan—JUN—Signaling events mediated by focal adhesion kinase—RHOA—membranous glomerulonephritis	0.00378	0.00554	CbGpPWpGaD
Irbesartan—EDNRA—Peptide ligand-binding receptors—C3—membranous glomerulonephritis	0.00369	0.0054	CbGpPWpGaD
Irbesartan—JUN—Endothelins—RHOA—membranous glomerulonephritis	0.00368	0.0054	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—PLG—membranous glomerulonephritis	0.00367	0.00538	CbGpPWpGaD
Irbesartan—JUN—LPA receptor mediated events—RHOA—membranous glomerulonephritis	0.00364	0.00533	CbGpPWpGaD
Irbesartan—JUN—AGE/RAGE pathway—RHOA—membranous glomerulonephritis	0.00355	0.0052	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—PTPRU—membranous glomerulonephritis	0.00353	0.00518	CbGpPWpGaD
Irbesartan—JUN—Wnt Signaling Pathway—RHOA—membranous glomerulonephritis	0.00351	0.00514	CbGpPWpGaD
Irbesartan—AGTR1—Allograft Rejection—IL1B—membranous glomerulonephritis	0.00346	0.00507	CbGpPWpGaD
Irbesartan—JUN—IL-1 signaling pathway—IL1B—membranous glomerulonephritis	0.00346	0.00507	CbGpPWpGaD
Irbesartan—CYP1A2—Phase 1 - Functionalization of compounds—TBXAS1—membranous glomerulonephritis	0.0034	0.00499	CbGpPWpGaD
Irbesartan—CYP2D6—Melatonin metabolism and effects—APOE—membranous glomerulonephritis	0.00335	0.00491	CbGpPWpGaD
Irbesartan—JUN—FGF signaling pathway—MMP9—membranous glomerulonephritis	0.00331	0.00485	CbGpPWpGaD
Irbesartan—CYP3A4—Cytochrome P450 - arranged by substrate type—TBXAS1—membranous glomerulonephritis	0.00324	0.00475	CbGpPWpGaD
Irbesartan—JUN—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—RHOA—membranous glomerulonephritis	0.00304	0.00446	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—C7—membranous glomerulonephritis	0.00297	0.00435	CbGpPWpGaD
Irbesartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—membranous glomerulonephritis	0.00293	0.0043	CbGpPWpGaD
Irbesartan—AGTR1—Peptide ligand-binding receptors—C3—membranous glomerulonephritis	0.00289	0.00424	CbGpPWpGaD
Irbesartan—JUN—LPA receptor mediated events—MMP9—membranous glomerulonephritis	0.00289	0.00423	CbGpPWpGaD
Irbesartan—CYP1A2—Melatonin metabolism and effects—APOE—membranous glomerulonephritis	0.00284	0.00416	CbGpPWpGaD
Irbesartan—JUN—AGE/RAGE pathway—MMP9—membranous glomerulonephritis	0.00282	0.00413	CbGpPWpGaD
Irbesartan—JUN—Androgen receptor signaling pathway—RHOA—membranous glomerulonephritis	0.00279	0.00409	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—PTPRU—membranous glomerulonephritis	0.00277	0.00406	CbGpPWpGaD
Irbesartan—JUN—AP-1 transcription factor network—MMP9—membranous glomerulonephritis	0.00269	0.00394	CbGpPWpGaD
Irbesartan—CYP3A4—Phase 1 - Functionalization of compounds—TBXAS1—membranous glomerulonephritis	0.00263	0.00385	CbGpPWpGaD
Irbesartan—CYP2C8—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.0026	0.00381	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—APOA1—membranous glomerulonephritis	0.00257	0.00376	CbGpPWpGaD
Irbesartan—JUN—Wnt Signaling Pathway and Pluripotency—RHOA—membranous glomerulonephritis	0.00251	0.00367	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—C3—membranous glomerulonephritis	0.00247	0.00362	CbGpPWpGaD
Irbesartan—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—membranous glomerulonephritis	0.00242	0.00354	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—RHOA—membranous glomerulonephritis	0.00238	0.00348	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CFH—membranous glomerulonephritis	0.00236	0.00345	CbGpPWpGaD
Irbesartan—JUN—TCR Signaling Pathway—IL1B—membranous glomerulonephritis	0.00233	0.00342	CbGpPWpGaD
Irbesartan—CYP2D6—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.00214	0.00313	CbGpPWpGaD
Irbesartan—JUN—PDGFR-beta signaling pathway—RHOA—membranous glomerulonephritis	0.00213	0.00312	CbGpPWpGaD
Irbesartan—CYP2C9—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.00212	0.0031	CbGpPWpGaD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—IL1B—membranous glomerulonephritis	0.00211	0.00309	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PTPRU—membranous glomerulonephritis	0.00207	0.00303	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—IL1B—membranous glomerulonephritis	0.00206	0.00302	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Signaling Pathway—RHOA—membranous glomerulonephritis	0.00204	0.00299	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—ALB—membranous glomerulonephritis	0.00204	0.00298	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—C3—membranous glomerulonephritis	0.00194	0.00284	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—C3—membranous glomerulonephritis	0.00188	0.00276	CbGpPWpGaD
Irbesartan—CYP1A2—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.00181	0.00265	CbGpPWpGaD
Irbesartan—JUN—Immune System—C7—membranous glomerulonephritis	0.00173	0.00253	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—IL1B—membranous glomerulonephritis	0.00166	0.00243	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—IL1B—membranous glomerulonephritis	0.00165	0.00241	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.00155	0.00226	CbGpPWpGaD
Irbesartan—JUN—Focal Adhesion—RHOA—membranous glomerulonephritis	0.00152	0.00223	CbGpPWpGaD
Irbesartan—JUN—Myometrial Relaxation and Contraction Pathways—IL1B—membranous glomerulonephritis	0.00151	0.00221	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—IL1B—membranous glomerulonephritis	0.0015	0.0022	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—C3—membranous glomerulonephritis	0.00148	0.00216	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—IL1B—membranous glomerulonephritis	0.00142	0.00207	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.0014	0.00204	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.00138	0.00202	CbGpPWpGaD
Irbesartan—JUN—Immune System—CFH—membranous glomerulonephritis	0.00137	0.00201	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	0.00133	0.00194	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—LRP2—membranous glomerulonephritis	0.00125	0.00184	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—membranous glomerulonephritis	0.00125	0.00183	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—TBXAS1—membranous glomerulonephritis	0.00122	0.00179	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—LRP2—membranous glomerulonephritis	0.00109	0.0016	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—C3—membranous glomerulonephritis	0.00106	0.00156	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PLA2G1B—membranous glomerulonephritis	0.00105	0.00154	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.000999	0.00146	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—LRP2—membranous glomerulonephritis	0.000984	0.00144	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—C3—membranous glomerulonephritis	0.000966	0.00142	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.00089	0.0013	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—C3—membranous glomerulonephritis	0.000889	0.0013	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	0.000888	0.0013	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	0.000857	0.00125	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—C3—membranous glomerulonephritis	0.000835	0.00122	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.000813	0.00119	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD40—membranous glomerulonephritis	0.000764	0.00112	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—C3—membranous glomerulonephritis	0.000758	0.00111	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—PLG—membranous glomerulonephritis	0.000751	0.0011	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—RHOA—membranous glomerulonephritis	0.00075	0.0011	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—LRP2—membranous glomerulonephritis	0.000735	0.00108	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.000724	0.00106	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD79A—membranous glomerulonephritis	0.000719	0.00105	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—ABCA1—membranous glomerulonephritis	0.000702	0.00103	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	0.000697	0.00102	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.000695	0.00102	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—TBXAS1—membranous glomerulonephritis	0.000689	0.00101	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—RHOA—membranous glomerulonephritis	0.000681	0.000998	CbGpPWpGaD
Irbesartan—JUN—Immune System—HLA-DQA1—membranous glomerulonephritis	0.000663	0.000971	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.000619	0.000907	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—LRP2—membranous glomerulonephritis	0.000614	0.000899	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	0.000596	0.000873	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PLA2G1B—membranous glomerulonephritis	0.000591	0.000865	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—PLG—membranous glomerulonephritis	0.000589	0.000863	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—RHOA—membranous glomerulonephritis	0.000588	0.000862	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD40LG—membranous glomerulonephritis	0.000586	0.000858	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	0.000584	0.000855	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	0.000577	0.000846	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	0.000574	0.00084	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—C3—membranous glomerulonephritis	0.000571	0.000836	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—RHOA—membranous glomerulonephritis	0.000534	0.000783	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—APOE—membranous glomerulonephritis	0.000531	0.000778	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—APOA1—membranous glomerulonephritis	0.000525	0.00077	CbGpPWpGaD
Irbesartan—JUN—Immune System—C3—membranous glomerulonephritis	0.000518	0.000758	CbGpPWpGaD
Irbesartan—JUN—Immune System—HLA-DRB1—membranous glomerulonephritis	0.000472	0.000691	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	0.000467	0.000684	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—APOE—membranous glomerulonephritis	0.000462	0.000676	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	0.000457	0.00067	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—APOA1—membranous glomerulonephritis	0.000457	0.000669	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—C3—membranous glomerulonephritis	0.000448	0.000656	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—TBXAS1—membranous glomerulonephritis	0.000445	0.000651	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PLG—membranous glomerulonephritis	0.00044	0.000645	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—APOE—membranous glomerulonephritis	0.000417	0.000611	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—APOA1—membranous glomerulonephritis	0.000412	0.000604	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—RHOA—membranous glomerulonephritis	0.000402	0.000589	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	0.000399	0.000584	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—LRP2—membranous glomerulonephritis	0.000396	0.000581	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ABCA1—membranous glomerulonephritis	0.000395	0.000579	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PLA2G1B—membranous glomerulonephritis	0.000382	0.000559	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	0.000377	0.000553	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	0.000373	0.000546	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—TBXAS1—membranous glomerulonephritis	0.000365	0.000535	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—TBXAS1—membranous glomerulonephritis	0.000362	0.00053	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—ALB—membranous glomerulonephritis	0.000362	0.00053	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—C3—membranous glomerulonephritis	0.000335	0.00049	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—LRP2—membranous glomerulonephritis	0.000325	0.000477	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—LRP2—membranous glomerulonephritis	0.000323	0.000473	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MMP9—membranous glomerulonephritis	0.000319	0.000468	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—RHOA—membranous glomerulonephritis	0.000316	0.000462	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PLA2G1B—membranous glomerulonephritis	0.000313	0.000459	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—APOE—membranous glomerulonephritis	0.000312	0.000456	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PLA2G1B—membranous glomerulonephritis	0.000311	0.000455	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—TBXAS1—membranous glomerulonephritis	0.000309	0.000453	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—APOA1—membranous glomerulonephritis	0.000308	0.000451	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL1B—membranous glomerulonephritis	0.000307	0.00045	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	0.000307	0.00045	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	0.000304	0.000445	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	0.000295	0.000433	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—LRP2—membranous glomerulonephritis	0.000276	0.000404	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PLA2G1B—membranous glomerulonephritis	0.000265	0.000389	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	0.000262	0.000384	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—APOE—membranous glomerulonephritis	0.00026	0.000381	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	0.000259	0.00038	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—APOA1—membranous glomerulonephritis	0.000257	0.000377	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ABCA1—membranous glomerulonephritis	0.000255	0.000374	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MMP9—membranous glomerulonephritis	0.000251	0.000367	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	0.00024	0.000352	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—TBXAS1—membranous glomerulonephritis	0.000239	0.00035	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—RHOA—membranous glomerulonephritis	0.000236	0.000345	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—LRP2—membranous glomerulonephritis	0.000213	0.000312	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ABCA1—membranous glomerulonephritis	0.00021	0.000307	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ABCA1—membranous glomerulonephritis	0.000208	0.000305	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	0.000206	0.000301	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PLA2G1B—membranous glomerulonephritis	0.000205	0.0003	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ALB—membranous glomerulonephritis	0.000204	0.000298	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MMP9—membranous glomerulonephritis	0.000187	0.000274	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ABCA1—membranous glomerulonephritis	0.000178	0.00026	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—APOE—membranous glomerulonephritis	0.000168	0.000246	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—APOA1—membranous glomerulonephritis	0.000166	0.000243	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—APOE—membranous glomerulonephritis	0.000138	0.000202	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ABCA1—membranous glomerulonephritis	0.000137	0.000201	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—APOE—membranous glomerulonephritis	0.000137	0.0002	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—APOA1—membranous glomerulonephritis	0.000136	0.0002	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—APOA1—membranous glomerulonephritis	0.000135	0.000198	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ALB—membranous glomerulonephritis	0.000132	0.000193	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—APOE—membranous glomerulonephritis	0.000117	0.000171	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—APOA1—membranous glomerulonephritis	0.000116	0.000169	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ALB—membranous glomerulonephritis	0.000108	0.000158	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ALB—membranous glomerulonephritis	0.000107	0.000157	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ALB—membranous glomerulonephritis	9.15e-05	0.000134	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOE—membranous glomerulonephritis	9.02e-05	0.000132	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOA1—membranous glomerulonephritis	8.91e-05	0.000131	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ALB—membranous glomerulonephritis	7.06e-05	0.000103	CbGpPWpGaD
